# Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT)

> **NCT00568464** · PHASE2 · TERMINATED · sponsor: **Fudan University** · enrollment: 10 (actual)

## Conditions studied

- Ewing's Sarcoma

## Interventions

- **DRUG:** VCR, CTX, ADM; IFO, VP-16

## Key facts

- **NCT ID:** NCT00568464
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03
- **Primary completion:** 2009-05
- **Final completion:** 2009-09
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** The enrollment is slower than expected
- **Last updated:** 2009-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00568464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00568464, "Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00568464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*